|Bid||30.11 x 3100|
|Ask||0.00 x 1000|
|Day's Range||34.46 - 35.70|
|52 Week Range||17.99 - 44.64|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.58|
Subscribe to Yahoo Finance Plus to view Fair Value for PRVA
The medical software stock sports a 97 Relative Strength Rating. Privia Health stock has now climbed above a proper buy zone after breaking out from a 29.07 buy point in a cup without handle. Privia Health stock earns a 98 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 98% of all stocks.
Privia Health is a top IPO stock to watch during the stock market sell-off. Shares are holding up despite the stock market volatility.
AAPL stock among 29 tech plays in demand among the best mutual funds as the technology sector emerges from exile.